Bellevue Funds (Lux) - Bellevue Diversified Healthcare U2 Fonds
128,39
CHF
-0,11
CHF
-0,09
%
NAV
Werbung
Anlageziel
The investment objective of the sub-fund is to achieve long-term capital growth by investing at least two thirds of the net assets of Bellevue Diversified Healthcare in a portfolio of carefully chosen shares and preference shares of companies in the health sector or companies whose main activity involves holding investments in such companies or financing such companies and that have their registered office or carry out the majority of their economic activity in recognised countries. Without restricting the scope of the term “healthcare”, the healthcare sector includes companies from the pharmaceutical, medical technology, biotechnology and related sectors.
Stammdaten
Name | Bellevue Funds (Lux) - Bellevue Diversified Healthcare U2 Acc CHF Fonds |
ISIN | LU2441707812 |
WKN | |
Fondsgesellschaft | Bellevue Asset Management Ltd. |
Benchmark | MSCI World Healthcare NR USD |
Ausschüttungsart | Thesaurierend |
Manager | |
Domizil | Luxembourg |
Fondskategorie | Aktien |
Auflagedatum | 31.03.2022 |
Geschäftsjahr | 30.06. |
VL-fähig? | Nein |
Depotbank | CACEIS Bank, Luxembourg Branch |
Zahlstelle | |
Riester Fonds | Nein |
Basisdaten
Auflagedatum | 31.03.2022 |
Depotbank | CACEIS Bank, Luxembourg Branch |
Zahlstelle | |
Domizil | Luxembourg |
Geschäftsjahr | 30.06. |
Aktuelle Daten
Morningstar Rating | |
Aktueller Rücknahmepreis | 128,39 |
Anzahl Fonds der Kategorie | 168 |
Volumen der Tranche | |
Fondsvolumen | 22,90 Mio. CHF |
Total Expense Ratio (TER) | 0,90 |
Gebühren
Laufende Kosten | 1,20% |
Total Expense Ratio (Verwaltungsgebühren & sonst. Kosten) | 0,90% |
Transaktionskosten | 0,30% |
Depotbankgebühr | - |
Managementgebühr | 0,60% |
Rücknahmegebühr | - |
Ausgabeaufschlag | - |
Performancedaten
Veränderung Vortag | -0,11 |
WE seit Jahresbeginn | 1,37% |